These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3696857)

  • 21. Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections.
    Yüksel S; Oztürk B; Kavaz A; Ozçakar ZB; Acar B; Güriz H; Aysev D; Ekim M; Yalçinkaya F
    Int J Antimicrob Agents; 2006 Nov; 28(5):413-6. PubMed ID: 17000085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cystic fibrosis (mucoviscidosis) as underlying cause of chronic obstructive pulmonary disease in children].
    Houstĕk J; Vávrová V; Nováková M
    Cas Lek Cesk; 1972 Apr; 111(16):353-7. PubMed ID: 5019481
    [No Abstract]   [Full Text] [Related]  

  • 23. A randomised comparison of isepamicin and amikacin in the treatment of bacterial infections in paediatric patients.
    Viganò A; Principi N
    J Chemother; 1995 Jun; 7 Suppl 2():95-101. PubMed ID: 8622117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Bacteriological monitoring of the treatment of Pseudomonas aeruginosa infections with amikacin administrated at once-daily dosis in patients with cystic fibrosis].
    Canis F; Husson MO; Vic P; Ategbo S; Turck D; Courcol R; Leclerc H
    Pathol Biol (Paris); 1995 Apr; 43(4):343-51. PubMed ID: 7567127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Respiratory deterioration and allergic bronchopulmonary aspergillosis in cystic fibrosis].
    Salcedo Posadas A
    Enferm Infecc Microbiol Clin; 2000; 18(6):301-3. PubMed ID: 11075497
    [No Abstract]   [Full Text] [Related]  

  • 26. [Plasma level of dibekacin in children with mucoviscidosis. Comparison with a control population].
    Loeuille GA; Cournol R; Delnatte J; Martin G
    Ann Pediatr (Paris); 1987 Nov; 34(9):713-7. PubMed ID: 3426082
    [No Abstract]   [Full Text] [Related]  

  • 27. Suction blisters technique in amikacin diffusion through interstitial fluid in cystic fibrosis.
    Vaillant L; Autret E; Marchand S; Lorette G; Grenier B
    Dev Pharmacol Ther; 1991; 16(1):29-32. PubMed ID: 1879249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective study of long-term use of amikacin in a paediatrics department. Indications, administration, side-effects, bacterial isolates and resistance.
    Hesseling PB; Mouton WL; Henning PA; Kirsten GF; Spruyt LL; Schraader EB; Wessels G; Grassman R
    S Afr Med J; 1990 Aug; 78(4):192-5. PubMed ID: 2382175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of tolerance and efficacy of pefloxacin in the treatment and prevention of severe infections in children with mucoviscidosis and aplastic anemia].
    Postnikov SS; Semykin SIu; Kapranov NI; Perederko LV; Polikarpova SV; Khamidullina KF
    Antibiot Khimioter; 2000; 45(8):25-30. PubMed ID: 10989721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mucoviscidosis. Antibiotic management].
    Le Bourgeois M; Gérardin M; Munck A; Navarro J
    Presse Med; 1997 May 3-10; 26(15):727-32. PubMed ID: 9183376
    [No Abstract]   [Full Text] [Related]  

  • 31. [Antibiotic therapy procedure in bacterial diseases in children (a lecture)].
    Malakhovskiĭ IuE; Manerov FK
    Vopr Okhr Materin Det; 1980 Feb; 25(2):38-43. PubMed ID: 7368642
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pseudomonas infections in lungs of children born with cystic fibrosis. Effects and adverse effects during antibiotic therapy with tobramycin and carbenicillin].
    Friis B; Thomsen J
    Ugeskr Laeger; 1979 Jul; 141(29):1968-72. PubMed ID: 545764
    [No Abstract]   [Full Text] [Related]  

  • 33. Amikacin as first-choice aminoglycoside in a medical intensive care unit: a one-year bacteriological surveillance study.
    Peetermans WE; Bobbaers HJ
    J Chemother; 1996 Feb; 8(1):17-24. PubMed ID: 8835103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Consensus: management of presumed bacterial pneumonia in ambulatory children.
    Grossman M; Klein JO; McCarthy PL; Schwartz RH; McCracken GH; Nelson JD
    Pediatr Infect Dis; 1984; 3(6):497-500. PubMed ID: 6334843
    [No Abstract]   [Full Text] [Related]  

  • 35. [A therapeutic protocol with cefoperazone in bronchopneumopathy in mucoviscidosis].
    Manca A; Giannuzzi R; Mazzei S; Nardelli F; Rigillo N
    Clin Ter; 1990 Dec; 135(5):347-53. PubMed ID: 2150364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infectious complications in bone marrow transplantation. Resistant bacterial infections.
    Jacoby GA
    Recent Results Cancer Res; 1993; 132():241-7. PubMed ID: 8265866
    [No Abstract]   [Full Text] [Related]  

  • 37. [Cellular immunity in chronic lung diseases and mucoviscidosis in children].
    Mikheeva GA; Turina IE
    Pediatriia; 1987; (11):101-2. PubMed ID: 3501568
    [No Abstract]   [Full Text] [Related]  

  • 38. [The results of antibiotic therapy in acute severe pneumonia dependent on the initial severity].
    Amstutz P; Blanloeil Y; Cathala B; Chopin C; Gouin F; Grimaud D; Le Gall JR; Rouby JJ; Tempe JD; Vanooteghem-Delbarre A
    Presse Med; 1990 Dec; 19(42):1948. PubMed ID: 2147761
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pathogenesis and diagnosis of bacterial airway infections in patients with cystic fibrosis].
    Möller AV; van Alphen L; Dankert-Roelse JE; Dankert J
    Ned Tijdschr Geneeskd; 1995 Nov; 139(46):2346-9. PubMed ID: 7501072
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical and pharmacological evaluation of cephapirin sodium (BL-P-1322) in infants and children (cephapirin in pediatric patients).
    Khan AJ; Pryles CV
    Curr Ther Res Clin Exp; 1973 Apr; 15(4):198-204. PubMed ID: 4633280
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.